Patient Monitoring Systems Market (2011 - 2016) - Global Trends, End-user & Value-Volume Analysis
NEW YORK, May 9, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Patient Monitoring Systems Market (2011 - 2016) - Global Trends, End-user & Value-Volume Analysishttp://www.reportlinker.com/p0848977/Patient-Monitoring-Systems-Market-2011---2016---Global-Trends-End-user--Value-Volume-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply
Patient Monitoring Devices / Equipments / Systems Market (2011 - 2016) (Remote Patient Monitoring, Blood Pressure, Blood Glucose, EEG, ECG, Sleep Apnea, Pulse Oximeter, Spirometer, Multi-Parameter, Fetal & Neonatal, Temperature, Weight) - Global Trends, End-user & Value-Volume Analysis
The patient monitoring devices market consists of segments like hemodynamic, neurology, cardiac, respiratory, fetal and neonatal, multi-parameter, remote patient monitors and temperature & weight management monitors. The global patient monitoring devices market was valued at $14.2 billion in 2011 and is poised to grow at a CAGR of 5.9% from 2011 to 2016 to reach $18.9 billion.
The market will be driven by increasing aging population, rising incidences of lifestyle diseases, home and remote monitors and increasing portability of equipments. However, the economic slowdown and unstable reimbursement policies will restrict the growth of this market to a certain extent.
North America is the biggest market, about 46%, for patient monitoring devices, followed by Europe with 27% share. However, the Asian countries represent the fastest growing markets due to large population and increased purchasing power of patients. Moreover, economic slowdown in western countries will compel the companies to focus on the Asian markets.
As end-users, hospitals occupy a share of 55% in the patient monitoring devices market, home monitoring accounts for 38.3% share. By 2016, hospitals will lose 2.8% share to home monitors owing to the fact that demand for home monitoring is increasing and strict government policies are being implemented to reduce patient stay in hospitals.
The major players in this market are Philips Healthcare (The Netherlands), GE Healthcare (UK), MindRay Medical (China), Omron Healthcare (Japan), Draeger Medical (Switzerland), Nihon Kohden (Japan), Masimo (U.S.), Covidien (Ireland), CareFusion (U.S.), Welch Allyn (U.S.), and Schiller AG (Switzerland)
Scope of the report Patient monitoring devices market, by segmentsHemodynamic monitoring devices
Blood glucose
Blood pressure
Blood cholesterol
Blood gas monitors
Neuromonitoring devices
Electroencephalograph (EEG)
Transcranial Dopplers (TCD)
Magnetoencephalograph (MEG)
Cardiac monitoring devices
Electrocardiogram (ECG / EKG)
Cardiac output monitors
Fetal and neonatal monitors
Ultrasound fetal Dopplers
Internal fetal monitors
Intrauterine pressure catheters
Respiratory monitors
Capnographs
Spirometers
Anesthesia monitors
Pulse oximeters
Sleep apnea monitors
Multi-parameter monitoring devices
Low acuity
Mid acuity
High acuity
Remote patient monitoring devices
Temperature and weight monitors
Patient monitoring devices market, by end-usersHome
Others (research and diagnostic centers)
Patient monitoring devices market, by geography: North AmericaEurope
APAC
ROW
The report does not include services and accessories market for patient monitoring devices.
TABLE OF CONTENTS1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 ASSUMPTIONS
2 EXECUTIVE SUMMARY
3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET DYNAMICS
3.2.1 DRIVERS
3.2.1.1 Increasing geriatric population to propel need of monitoring devices
3.2.1.2 Increasing incidences of lifestyle diseases is projected to fuel need of patient monitoring devices
3.2.1.3 Home & remote monitoring, an essential factor driving patient monitoring devices market
3.2.1.4 Ease-of-use & portability of devices to push Point-of-Care monitoring devices
3.2.2 RESTRAINTS
3.2.2.1 Economic downturn & saturation to slow growth of monitoring devices market
3.2.2.2 Unstable reimbursement regulations to restrict growth in patient monitoring devices market
3.2.3 OPPORTUNITIES
3.2.3.1 Private institutional nursing
3.2.3.2 M&A and Joint Ventures
3.3 MARKET SEGMENTATION
3.4 MARKET SHARE ANALYSIS
3.4.1 MARKET SHARE ANALYSIS OF KEY PLAYERS
3.4.2 HEMODYNAMIC MONITOR
3.4.2.1 Blood pressure monitor
3.4.2.2 Single point blood glucose monitor
3.4.2.3 Continuous blood glucose monitor
3.4.2.4 Blood gas analyzers
3.4.3 NEUROMONITOR
3.4.3.1 EEG
3.4.3.2 TCD
3.4.3.3 MEG
3.4.4 CARDIAC MONITOR
3.4.4.1 ECG
3.4.5 RESPIRATORY MONITOR
3.4.5.1 Capnograph
3.4.5.2 Spirometer
3.4.5.3 Anesthesia monitor
3.4.5.4 Sleep apnea monitor
3.4.5.5 Pulse oximeter
3.4.6 FETAL & NEONATAL
3.4.7 MULTI-PARAMETER
3.4.8 REMOTE PATIENT MONITORING DEVICES
3.5 END-USER ANALYSIS
4 HEMODYNAMIC MONITORING DEVICES
4.1 INTRODUCTION
4.2 DRIVERS & OPPORTUNITIES
4.2.1 INCREASE OF HYPERTENSION CASES
4.2.2 INCREASE IN DIABETIC POPULATION
4.2.3 NON-INVASIVE DEVICES
4.2.4 INCREASING POPULATION OPTING FOR SELF-MONITORING DEVICES
4.3 RESTRAINT
4.3.1 HIGH FRAGMENTATION IN COMPETITORS FOR HEMODYNAMIC MONITORING DEVICES
4.4 BLOOD PRESSURE MONITORING DEVICES
4.5 BLOOD GLUCOSE MONITORING DEVICES
4.5.1 MARKET DYNAMICS
4.5.1.1 Advancing technology
4.5.1.2 Decreasing value of blood glucose kits to reduce market size & restrain growth
4.5.1.3 Untapped potential present in large population of undiagnosed diabetics
4.6 BLOOD GAS ANALYZERS/MONITORS
4.6.1 DRIVERS & RESTRAINTS
4.6.1.1 Inadequacy of alternate techniques provides stable growth for invasive blood gas analyzers
4.6.1.2 Complex operation & interpretation restricts use of these devices & reduces growth of market
4.7 CHOLESTEROL MONITORING DEVICES
5 NEUROLOGICAL MONITORING DEVICES
5.1 INTRODUCTION
5.2 DRIVERS
5.2.1 INCREASING INCIDENCES OF NEURO-DEGENERATIVE DISEASES, A MAJOR DRIVER FOR NEUROMONITORING DEVICES
5.2.2 RISING AWARENESS & EXPOSURE TO LITERATURE OF NEURO-DEGENERATIVE DISEASES
5.2.3 ADVANCED TECHNOLOGY
5.2.4 MONITORING FOR INVALIDS & INFANTS TO DRIVE NEUROMONITORING ALONG WITH OTHER RESEARCH
5.3 RESTRAINTS
5.3.1 DIFFICULTY IN EARLY DETECTION
5.3.2 COMPLEX INTERPRETATION RESTRICTS USE OF THESE DEVICES & SLOWS GROWTH
5.4 OPPORTUNITIES
5.4.1 TELEMETRIC NEUROMONITORING SHOW ADVANCED OPTIONS IN NEUROMONITORING
5.5 ELECTROENCEPHALOGRAPH (EEG)
5.6 TRANSCRANIAL DOPPLER (TCD)
5.7 MAGNETOENCEPHALOGRAPH (MEG)
5.8 INTRACRANIAL PRESSURE MONITORS (ICP)
5.9 CEREBRAL OXIMETER
6 CARDIAC MONITORING DEVICES
6.1 INTRODUCTION
6.2 DRIVERS & OPPORTUNITY
6.2.1 INCREASING INCIDENCES OF CARDIOVASCULAR DISEASES, A PRIMARY DRIVER
6.2.2 RISE IN COST OF HEART DISEASE TREATMENT WILL PUSH MARKET GROWTH FOR MONITORING
6.2.3 ECG DATA MANAGEMENT SYSTEMS, A RISING OPPORTUNITY
6.3 ECG/EKG DEVICES
6.3.1 MARKET DYNAMICS
6.3.1.1 Increasing incidence of CVD to boost the growth of ECG monitors
6.3.1.2 Technological advances to drive the growth of ECG telemetry devices
6.3.1.3 Asian region improves the growth prospects
6.3.1.4 Market maturity
6.4 CARDIAC OUTPUT MONITORING DEVICES
7 FETAL & NEONATAL MONITORING DEVICES
7.1 INTRODUCTION
7.2 DRIVERS & OPPORTUNITIES
7.2.1 HIGH NUMBER OF PRETERM BIRTHS
7.2.2 INCREASED RATE OF PREGNANCY
7.2.3 INCREASED ACCESS TO PREGNANCY INFORMATION
7.2.4 LOWERING COST FOR BUYING AND RENTING MONITORING EQUIPMENT WILL INCREASE USE OF FETAL & NEONATAL MONITORS
7.2.5 PORTABLE & WIRELESS DOPPLER
7.3 RESTRAINTS
7.3.1 GOVERNMENT REGULATIONS RESTRICT SALE OF FETAL MONITORING DEVICES
8 RESPIRATORY MONITORING DEVICES
8.1 INTRODUCTION
8.2 DRIVERS
8.2.1 RISING FOCUS ON MONITORING RESPIRATORY DISEASES
8.2.2 INCREASING INCIDENCES OF RESPIRATORY DISEASES
8.2.3 GOVERNMENT REGULATIONS
8.2.4 POLLUTION, HABITUAL SMOKING HAS INCREASED THE DRIVE FOR RESPIRATORY MONITORING DEVICES
8.3 CAPNOGRAPHS
8.3.1 DRIVER & RESTRAINT
8.3.1.1 Alternate uses
8.3.1.2 Market maturity & saturation to slow the growth of respiratory monitors
8.4 SPIROMETER DEVICES
8.5 ANESTHESIA MONITORS
8.6 SLEEP APNEA MONITORING DEVICES
8.6.1 DRIVER
8.6.1.1 Increasing incidence of obstructive sleep apnea (OSA)
8.7 PULSE OXIMETERS
8.7.1 DRIVER & RESTRAINT
8.7.1.1 Adoption of new technology & increase in the awareness to propel the growth
8.7.1.2 Multi-parameter integration to restrain stand-alone device market
9 MULTI-PARAMETER MONITORING DEVICES
9.1 INTRODUCTION
9.2 DRIVERS & OPPORTUNITIES
9.2.1 INCREASING NUMBER OF HOSPITALIZATIONS THROUGHOUT THE WORLD TO DRIVE THE MULTI-PARAMETER MARKET
9.2.2 REMOTE MONITORING AND HOME MONITORING TO DRIVE MID-ACUITY AND LOW-ACUITY SEGMENT
9.2.3 WIRELESS AND PORTABLE MONITORS MARKET - A NEW OPPORTUNITY
10 REMOTE PATIENT MONITORING DEVICES MARKET
10.1 INTRODUCTION
10.2 DRIVERS & RESTRAINT
10.2.1 GOVERNMENT REGULATIONS TO CURB HEALTHCARE COSTS
10.2.2 AGING POPULATION
10.2.3 TECHNOLOGICAL ADVANCES
10.2.4 HEALTH CARE CONSUMERISM PATTERN
10.2.5 COST OF REMOTE PATIENT MONITORING DEVICES, A RESTRAINT
10.3 OPPORTUNITIES
10.3.1 NASCENT STAGE OF MARKET
10.3.2 MERGERS, ACQUISITIONS, JOINT VENTURES & COLLABORATIONS OPPORTUNITIES
11 OTHER MONITORS (WEIGHT & TEMPERATURE)
11.1 INTRODUCTION
11.2 WEIGHT MONITORING DEVICES
11.3 RESTRAINT
11.3.1 HIGHLY SATURATED & MATURED MARKET REDUCES SCOPE FOR GROWTH & PROFIT
11.4 TEMPERATURE MONITORING DEVICES
11.4.1 DRIVERS
11.4.1.1 Rising number of health conscious consumers driving the market
11.4.1.2 Technological innovations to boost the market growth
12 GEOGRAPHIC ANALYSIS
12.1 OVERVIEW
12.2 NORTH AMERICA
12.3 EUROPE
12.4 ASIA-PACIFIC
12.5 REST OF THE WORLD (ROW)
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 MERGERS & ACQUISITIONS
13.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
13.4 NEW PRODUCTS LAUNCH
13.5 OTHER DEVELOPMENTS
14 COMPANY PROFILES
14.1 A&D COMPANY LTD
14.1.1 OVERVIEW
14.1.2 PRODUCTS & SERVICES
14.1.3 FINANCIALS
14.1.4 STRATEGY
14.1.5 DEVELOPMENTS
14.2 ABBOTT LABORATORIES
14.2.1 OVERVIEW
14.2.2 PRODUCTS & SERVICES
14.2.3 FINANCIALS
14.2.4 STRATEGY
14.2.5 DEVELOPMENTS
14.3 AMBU INC.
14.3.1 OVERVIEW
14.3.2 PRODUCTS & SERVICES
14.3.3 FINANCIALS
14.3.4 STRATEGY
14.3.5 DEVELOPMENTS
14.4 BRIGGS MEDICAL SERVICE COMPANY
14.4.1 OVERVIEW
14.4.2 PRODUCTS & SERVICES
14.4.3 FINANCIALS
14.4.4 STRATEGY
14.4.5 DEVELOPMENTS
14.5 CARDIOCOM LLC
14.5.1 OVERVIEW
14.5.2 PRODUCTS & SERVICES
14.5.3 FINANCIALS
14.5.4 STRATEGY
14.5.5 DEVELOPMENTS
14.6 CARDIONET INC.
14.6.1 OVERVIEW
14.6.2 PRODUCTS & SERVICES
14.6.3 FINANCIALS
14.6.4 STRATEGY
14.6.5 DEVELOPMENTS
14.7 CAREFUSION CORPORATION
14.7.1 OVERVIEW
14.7.2 PRODUCTS & SERVICES
14.7.3 FINANCIALS
14.7.4 STRATEGY
14.7.5 DEVELOPMENTS
14.8 COMPUMEDICS
14.8.1 OVERVIEW
14.8.2 PRODUCTS & SERVICES
14.8.3 FINANCIALS
14.8.4 STRATEGY
14.8.5 DEVELOPMENTS
14.9 CONMED
14.9.1 OVERVIEW
14.9.2 PRODUCTS & SERVICES
14.9.3 FINANCIALS
14.9.4 STRATEGY
14.9.5 DEVELOPMENT
14.1 CONTEC MEDICAL SYSTEMS CO. LTD.
14.10.1 OVERVIEW
14.10.2 PRODUCTS & SERVICES
14.10.3 FINANCIALS
14.10.4 STRATEGY
14.11 COVIDIEN
14.11.1 OVERVIEW
14.11.2 PRODUCTS & SERVICES
14.11.3 FINANCIALS
14.11.4 STRATEGY
14.11.5 DEVELOPMENTS
14.12 DRAEGER MEDICAL GMBH
14.12.1 OVERVIEW
14.12.2 PRODUCTS & SERVICES
14.12.3 FINANCIALS
14.12.4 DEVELOPMENTS
14.13 EDWARDS LIFESCIENCES
14.13.1 OVERVIEW
14.13.2 PRODUCTS & SERVICES
14.13.3 FINANCIALS
14.13.4 STRATEGY
14.13.5 DEVELOPMENTS
14.14 ELEKTA
14.14.1 OVERVIEW
14.14.2 PRODUCTS & SERVICES
14.14.3 FINANCIALS
14.14.4 STRATEGY
14.14.5 DEVELOPMENTS
14.15 FISHER & PAYKEL HEALTHCARE LTD
14.15.1 OVERVIEW
14.15.2 PRODUCTS & SERVICES
14.15.3 FINANCIALS
14.15.4 STRATEGY
14.16 FUKUDA DENSHI COMPANY LTD.
14.16.1 OVERVIEW
14.16.2 PRODUCTS & SERVICES
14.16.3 FINANCIALS
14.16.4 STRATEGY
14.16.5 DEVELOPMENTS
14.17 GE HEALTHCARE
14.17.1 OVERVIEW
14.17.2 PRODUCTS & SERVICES
14.17.3 FINANCIALS
14.17.4 STRATEGY
14.17.5 DEVELOPMENTS
14.18 HONEYWELL INTERNATIONAL INC.
14.18.1 OVERVIEW
14.18.2 PRODUCTS & SERVICES
14.18.3 FINANCIALS
14.18.4 STRATEGY
14.18.5 DEVELOPMENTS
14.19 INTOUCH HEALTH
14.19.1 OVERVIEW
14.19.2 PRODUCTS & SERVICES
14.19.3 FINANCIALS
14.19.4 STRATEGY
14.19.5 DEVELOPMENTS
14.20 JOHNSON & JOHNSON INC.
14.20.1 OVERVIEW
14.20.2 PRODUCTS & SERVICES
14.20.3 FINANCIALS
14.20.4 STRATEGY
14.20.5 DEVELOPMENTS
14.21 LARSEN & TOUBRO LIMITED (L&T LTD)
14.21.1 OVERVIEW
14.21.2 PRODUCTS & SERVICES
14.21.3 FINANCIALS
14.21.4 STRATEGY
14.21.5 DEVELOPMENTS
14.22 LIFEWATCH AG
14.22.1 OVERVIEW
14.22.2 PRODUCTS & SERVICES
14.22.3 FINANCIALS
14.22.4 STRATEGY
14.22.5 DEVELOPMENTS
14.23 MASIMO CORPORATION
14.23.1 OVERVIEW
14.23.2 PRODUCTS & SERVICES
14.23.3 FINANCIALS
14.23.4 STRATEGY
14.23.5 DEVELOPMENTS
14.24 MINDRAY
14.24.1 OVERVIEW
14.24.2 PRODUCTS & SERVICES
14.24.3 FINANCIALS
14.24.4 STRATEGY
14.24.5 DEVELOPMENTS
14.25 MORTARA INSTRUMENT INC.
14.25.1 OVERVIEW
14.25.2 PRODUCTS & SERVICES
14.25.3 FINANCIALS
14.25.4 STRATEGY
14.25.5 DEVELOPMENTS
14.26 NATUS
14.26.1 OVERVIEW
14.26.2 PRODUCTS & SERVICES
14.26.3 FINANCIALS
14.26.4 STRATEGY
14.26.5 DEVELOPMENTS
14.27 NIHON KOHDEN
14.27.1 OVERVIEW
14.27.2 PRODUCTS & SERVICES
14.27.3 FINANCIALS
14.27.4 STRATEGY
14.27.5 DEVELOPMENTS
14.28 NONIN MEDICAL
14.28.1 OVERVIEW
14.28.2 PRODUCTS & SERVICES
14.28.3 FINANCIALS
14.28.4 STRATEGY
14.28.5 DEVELOPMENTS
14.29 OMRON
14.29.1 OVERVIEW
14.29.2 PRODUCTS & SERVICES
14.29.3 FINANCIALS
14.29.4 STRATEGY
14.29.5 DEVELOPMENTS
14.30 ORIDION
14.30.1 OVERVIEW
14.30.2 PRODUCTS & SERVICES
14.30.3 FINANCIALS
14.30.4 STRATEGY
14.30.5 DEVELOPMENTS
14.31 OSI SYSTEMS INC.
14.31.1 OVERVIEW
14.31.2 PRODUCTS & SERVICES
14.31.3 FINANCIALS
14.31.4 STRATEGY
14.31.5 DEVELOPMENTS
14.32 ROBERT BOSCH HEALTHCARE INC.
14.32.1 OVERVIEW
14.32.2 PRODUCTS & SERVICES
14.32.3 FINANCIALS
14.32.4 STRATEGY
14.32.5 DEVELOPMENTS
14.33 ROCHE DIAGNOSTICS LIMITED
14.33.1 OVERVIEW
14.33.2 PRODUCTS & SERVICES
14.33.3 FINANCIALS
14.33.4 STRATEGY
14.33.5 DEVELOPMENTS
14.34 ROYAL PHILIPS HEALTHCARE
14.34.1 OVERVIEW
14.34.2 PRODUCTS & SERVICES
14.34.3 FINANCIALS
14.34.4 STRATEGY
14.34.5 DEVELOPMENTS
14.35 SCHILLER AG
14.35.1 OVERVIEW
14.35.2 PRODUCTS & SERVICES
14.35.3 FINANCIALS
14.35.4 STRATEGY
14.35.5 DEVELOPMENTS
14.36 SECA GMBH & CO. KG.
14.36.1 OVERVIEW
14.36.2 PRODUCTS & SERVICES
14.36.3 FINANCIALS
14.36.4 STRATEGY
14.36.5 DEVELOPMENTS
14.37 SIEMENS HEALTHCARE
14.37.1 OVERVIEW
14.37.2 PRODUCTS & SERVICES
14.37.3 FINANCIALS
14.37.4 STRATEGY
14.37.5 DEVELOPMENTS
14.38 SMITHS MEDICAL
14.38.1 OVERVIEW
14.38.2 PRODUCTS & SERVICES
14.38.3 FINANCIALS
14.38.4 STRATEGY
14.38.5 DEVELOPMENTS
14.39 WELCH ALLYN
14.39.1 OVERVIEW
14.39.2 PRODUCTS & SERVICES
14.39.3 FINANCIALS
14.39.4 STRATEGY
14.39.5 DEVELOPMENTS
14.40 YOKOGAWA ELECTRIC CORPORATION
14.40.1 OVERVIEW
14.40.2 PRODUCTS & SERVICES
14.40.3 FINANCIALS
14.40.4 STRATEGY
LIST OF TABLESBY SEGMENTS ($MILLION)
TABLE 2 GLOBAL PATIENT MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 3 PATIENT MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 4 GLOBAL HEMODYNAMIC MONITORS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 5 HEMODYNAMIC MONITORS MARKET REVENUE, BY GEOGRAPHY,
2009 - 2016 ($MILLION)
TABLE 6 BLOOD PRESSURE MONITORS MARKET REVENUE, BY TECHNOLOGIES, 2009 - 2016 ($MILLION)
TABLE 7 GLOBAL BLOOD PRESSURE MONITORS MARKET REVENUE,
BY SITE OF USAGES, 2009 - 2016 ($MILLION)
TABLE 8 GLOBAL BLOOD PRESSURE MONITORS MARKET VOLUME,
BY SITE OF USAGES, 2009 - 2016 (MILLION UNITS)
TABLE 9 BLOOD PRESSURE MONITORS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 10 BLOOD PRESSURE MONITORS MARKET VOLUME, BY GEOGRAPHY,
2009 - 2016 (MILLION UNITS)
TABLE 11 GLOBAL BLOOD PRESSURE MONITORS MARKET REVENUE,
BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 12 GLOBAL BLOOD GLUCOSE MONITORS MARKET REVENUE,
BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 13 GLOBAL BLOOD GLUCOSE MONITORS MARKET VOLUME,
BY PRODUCTS, 2009 - 2016 (MILLION UNITS)
TABLE 14 CONTINUOUS BLOOD GLUCOSE MONITOR MARKET REVENUE,
BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 15 SINGLE-POINT BLOOD GLUCOSE MONITOR MARKET REVENUE,
BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 16 BLOOD GLUCOSE MONITOR MARKET REVENUE, BY GEOGRAPHY,
2009 - 2016 ($MILLION)
TABLE 17 BLOOD GLUCOSE MONITOR MARKET VOLUME, BY GEOGRAPHY,
2009 - 2016 (MILLION UNITS)
TABLE 18 GLOBAL BLOOD GLUCOSE MONITORS MARKET REVENUE,
BY END-USER, 2009 - 2016 ($MILLION)
TABLE 19 GLOBAL BLOOD GAS ANALYZERS MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 20 GLOBAL BLOOD GAS ANALYZERS MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 21 GLOBAL BLOOD GAS ANALYZERS MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 22 POC BLOOD GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY,
2009 - 2016 ($MILLION)
TABLE 23 POC BLOOD GAS ANALYZERS MARKET VOLUME, BY GEOGRAPHY,
2009 - 2016 (THOUSAND UNITS)
TABLE 24 DESKTOP BLOOD GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 25 DESKTOP BLOOD GAS ANALYZERS MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 26 BLOOD GAS ANALYZERS MARKET REVENUE, BY GEOGRAPHY,
2009 - 2016 ($MILLION)
TABLE 27 GLOBAL BLOOD GAS ANALYZERS MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 28 CHOLESTEROL MONITORS MARKET REVENUE, BY GEOGRAPHY,
2009 - 2016 ($MILLION)
TABLE 29 CHOLESTEROL MONITORS MARKET VOLUME, BY GEOGRAPHY,
2009 - 2016 (MILLION UNITS)
TABLE 30 CHOLESTEROL MONITORS MARKET REVENUE, BY END-USERS,
2009 - 2016 ($MILLION)
TABLE 31 GLOBAL NEUROMONITOR MARKET REVENUE, BY PRODUCTS,
2009 - 2016 ($MILLION)
TABLE 32 NEUROMONITOR MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 33 EEG MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 34 EEG MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016
(THOUSAND UNITS)
TABLE 35 GLOBAL EEG MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 36 TCD MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 37 TCD MARKET VOLUME, BY GEOGRAPHY, 2009 – 2016
(THOUSAND UNITS)
TABLE 38 GLOBAL TCD MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 39 MEG MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 40 MEG MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (NO. OF UNITS)
TABLE 41 GLOBAL MEG MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 42 GLOBAL CARDIAC MONITOR MARKET REVENUE, BY PRODUCTS,
2009 - 2016 ($MILLION)
TABLE 43 CARDIAC MONITOR MARKET REVENUE, BY GEOGRAPHY,
2009 - 2016 ($MILLION)
TABLE 44 GLOBAL ECG DEVICES MARKET REVENUE, BY PRODUCTS,
2009 - 2016 ($MILLION)
TABLE 45 GLOBAL ECG DEVICES MARKET VOLUME, BY PRODUCTS,
2009 - 2016 (THOUSAND UNITS)
TABLE 46 GLOBAL ECG DEVICES MARKET REVENUE, BY NO. OF LEADS,
2009 - 2016 ($MILLION)
TABLE 47 ECG DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 48 ECG DEVICES MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 49 GLOBAL ECG DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 50 CARDIAC OUTPUT MONITORING DEVICES MARKET REVENUE,
BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 51 CARDIAC OUTPUT MONITORING DEVICES MARKET VOLUME,
BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 52 GLOBAL CARDIAC OUTPUT MONITORING DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 53 FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE,
BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 54 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 55 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (MILLION UNITS)
TABLE 56 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY APPLICATIONS, 2009 - 2016 ($MILLION)
TABLE 57 FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE,
BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 58 FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE,
BY GEOGRAPHY, 2009 - 2016 (VOLUME)
TABLE 59 INTERNAL FETAL MONITORING DEVICES MARKET REVENUE,
BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 60 FETAL & NEONATAL INTRAUTERINE PRESSURE CATHETERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 61 FETAL & NEONATAL ULTRASOUND FETAL DOPPLERS MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 62 GLOBAL FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 63 GLOBAL RESPIRATORY MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 64 RESPIRATORY MONITORING DEVICES MARKET REVENUE,
BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 65 GLOBAL CAPNOGRAPH MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 66 GLOBAL CAPNOGRAPH MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 67 GLOBAL CAPNOGRAPH MARKET REVENUE, BY TECHNOLOGIES,
2009 - 2016 ($MILLION)
TABLE 68 CAPNOGRAPH MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 69 CAPNOGRAPH MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 70 GLOBAL CAPNOGRAPH MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 71 GLOBAL SPIROMETER MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 72 GLOBAL SPIROMETER MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 73 GLOBAL SPIROMETER MARKET REVENUE, BY TECHNOLOGIES,
2009 - 2016 ($MILLION)
TABLE 74 SPIROMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 75 SPIROMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 76 GLOBAL SPIROMETER MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 77 GLOBAL ANAESTHESIA MONITOR MARKET REVENUE, BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 78 GLOBAL ANAESTHESIA MONITOR MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 79 ANESTHESIA MONITOR MARKET REVENUE, BY GEOGRAPHY,
2009 - 2016 ($MILLION)
TABLE 80 ANESTHESIA MONITOR MARKET VOLUME, BY GEOGRAPHY,
2009 - 2016 (THOUSAND UNITS)
TABLE 81 GLOBAL ANAESTHESIA MONITOR MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 82 GLOBAL SLEEP APNEA MONITORING DEVICE MARKET REVENUE,
BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 83 GLOBAL SLEEP APNEA MONITORING DEVICE MARKET REVENUE,
BY PRODUCTS, 2009 - 2016 (THOUSAND UNITS)
TABLE 84 SLEEP APNEA MONITORING DEVICE MARKET REVENUE,
BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 85 SLEEP APNEA MONITORING DEVICE MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 86 GLOBAL SLEEP APNEA MONITORING DEVICE MARKET REVENUE,
BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 87 GLOBAL PULSE OXIMETER MARKET REVENUE, BY PRODUCTS,
2009 - 2016 ($MILLION)
TABLE 88 GLOBAL PULSE OXIMETER MARKET VOLUME, BY PRODUCTS,
2009 - 2016 (THOUSAND UNITS)
TABLE 89 PULSE OXIMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 90 PULSE OXIMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 91 GLOBAL PULSE OXIMETER MARKET REVENUE, BY END-USERS,
2009 - 2016 ($MILLION)
TABLE 92 GLOBAL MULTI-PARAMETER MARKET REVENUE, BY ACUITY,
2009 - 2016 ($MILLION)
TABLE 93 GLOBAL MULTI-PARAMETER MARKET VOLUME, BY ACUITY, 2009 - 2016 (THOUSAND UNITS)
TABLE 94 MULTI-PARAMETER HIGH ACUITY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 95 MULTI-PARAMETER MID ACUITY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 96 MULTI-PARAMETER LOW ACUITY MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 97 MULTI-PARAMETER MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 98 MULTI-PARAMETER MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 99 GLOBAL MULTI-PARAMETER MARKET REVENUE, BY END-USERS,
2009 - 2016 ($MILLION)
TABLE 100 REMOTE PATIENT MONITORING DEVICES MARKET REVENUE,
BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 101 GLOBAL REMOTE PATIENT MONITORING DEVICES MARKET REVENUE, BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 102 GLOBAL OTHER MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 103 OTHER MONITORING DEVICES MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 104 GLOBAL WEIGHT MONITORING MARKET REVENUE, BY PRODUCTS,
2009 - 2016 ($MILLION)
TABLE 105 GLOBAL WEIGHT MONITORING MARKET VOLUME, BY PRODUCTS,
2009 - 2016 (THOUSAND UNITS)
TABLE 106 WEIGHT MONITORING MARKET REVENUE, BY GEOGRAPHY, 2009 - 2016 ($MILLION)
TABLE 107 WEIGHT MONITORING MARKET VOLUME, BY GEOGRAPHY, 2009 - 2016 (THOUSAND UNITS)
TABLE 108 GLOBAL WEIGHT MONITORING MARKET REVENUE, BY END-USERS,
2009 - 2016 ($MILLION)
TABLE 109 GLOBAL TEMPERATURE MONITORING MARKET REVENUE,
BY PRODUCTS, 2009 - 2016 ($MILLION)
TABLE 110 GLOBAL TEMPERATURE MONITORING MARKET VOLUME, BY PRODUCTS, 2009 - 2016 (MILLION UNITS)
TABLE 111 TEMPERATURE MONITORING MARKET REVENUE, BY GEOGRAPHY,
2009 - 2016 ($MILLION)
TABLE 112 TEMPERATURE MONITORING MARKET VOLUME, BY GEOGRAPHY,
2009 - 2016 (MILLION UNITS)
TABLE 113 GLOBAL TEMPERATURE MONITORING MARKET REVENUE,
BY END-USERS, 2009 - 2016 ($MILLION)
TABLE 114 NORTH AMERICA: PATIENT MONITORING DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 115 NORTH AMERICA: HEMODYNAMIC MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 116 NORTH AMERICA: NEUROMONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 117 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 118 NORTH AMERICA: FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 119 NORTH AMERICA: RESPIRATORY MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 120 NORTH AMERICA: MULTI-PARAMETER MONITORING DEVICES MARKET REVENUE, BY ACUITY, 2009 – 2016 ($MILLION)
TABLE 121 NORTH AMERICA OTHER MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 122 EUROPE: PATIENT MONITORING DEVICES MARKET REVENUE,
BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 123 EUROPE: HEMODYNAMIC MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 124 EUROPE: NEUROMONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 125 EUROPE: CARDIAC MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 126 EUROPE: FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 127 EUROPE: RESPIRATORY MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 128 EUROPE: MULTI-PARAMETER MONITORING DEVICES MARKET REVENUE, BY ACUITY, 2009 – 2016 ($MILLION)
TABLE 129 EUROPE: OTHER PATIENT MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 130 APAC: PATIENT HEALTHCARE MONITORING DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 131 APAC: HEMODYNAMIC PATIENT MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 132 APAC: NEUROMONITORING PATIENT MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 133 APAC: CARDIAC PATIENT MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 134 APAC: FETAL & NEONATAL PATIENT MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 135 APAC: RESPIRATORY PATIENT MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 136 APAC: MULTI-PARAMETER PATIENT MONITORING DEVICES MARKET REVENUE, BY ACUITY, 2009 – 2016 ($MILLION)
TABLE 137 APAC: OTHER PATIENT MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 138 ROW: PATIENT HEALTHCARE MONITORING DEVICES MARKET REVENUE, BY SEGMENTS, 2009 – 2016 ($MILLION)
TABLE 139 ROW: HEMODYNAMIC MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 140 ROW: NEUROMONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 141 ROW: CARDIAC MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 142 ROW: FETAL & NEONATAL MONITORING DEVICES MARKET REVENUE, BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 143 ROW: RESPIRATORY MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 144 ROW: MULTI-PARAMETER MONITORING DEVICES MARKET REVENUE,
BY ACUITY, 2009 – 2016 ($MILLION)
TABLE 145 ROW: OTHER PATIENT MONITORING DEVICES MARKET REVENUE,
BY PRODUCTS, 2009 – 2016 ($MILLION)
TABLE 146 MERGERS & ACQUISITIONS, JANUARY 2009 – MARCH 2012
TABLE 147 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, JANUARY, 2009 – APRIL 2012
TABLE 148 NEW PRODUCTS LAUNCH, JANUARY 2009 – MARCH 2012
TABLE 149 OTHER DEVELOPMENTS, JANUARY 2009 – MARCH 2012
TABLE 150 A & D COMPANY LTD.: TOTAL REVENUE AND R&D EXPENSES,
2009 - 2011 ($MILLION)
TABLE 151 A & D COMPANY LTD.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 152 A&D COMPANY LTD: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 153 ABBOTT LABORATORIES: NET SALES AND R&D EXPENDITURE,
2008 – 2010 ($BILLION)
TABLE 154 ABBOTT LABORATORIES: NET SALES, BY SEGMENTS, 2008 – 2010 ($MILLION)
TABLE 155 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY,
2008 – 2010 ($MILLION)
TABLE 156 AMBU: NET SALES AND R&D EXPENDITURE, 2008 – 2010 ($BILLION)
TABLE 157 AMBU: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011($MILLION)
TABLE 158 AMBU: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011($MILLION)
TABLE 159 CARDIONET INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 160 CARDIONET INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 161 CAREFUSION: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 162 CAREFUSION: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 163 CAREFUSION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 164 COMPUMEDICS: TOTAL REVENUE AND R&D EXPENSES,
2009 - 2011($MILLION)
TABLE 165 COMPUMEDICS: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 166 COMPUMEDICS: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 167 CONMED: NET SALES AND R&D EXPENSES,2009 - 2011 ($MILLION)
TABLE 168 CONMED: NET SALES, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 169 CONMED: NET SALES, BY GEOGRAPHY, 2008 – 2010 ($MILLION)
TABLE 170 COVIDIEN: NET SALES AND R&D EXPENSES, 2009 - 2011($MILLION)
TABLE 171 COVIDIEN: NET SALES, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 172 COVIDIEN: NET SALES, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 173 DRAEGER: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 174 DRAEGER: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 175 EDWARDS LIFESCIENCES: NET SALES AND R&D EXPENSES,
2008 – 2010 ($MILLION)
TABLE 176 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE,
BY GEOGRAPHY, 2009-2011 ($MILLION)
TABLE 177 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE,
BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 178 ELEKTA: TOTAL REVENUE AND R&D EXPENSES, 2008-2010 ($MILLION)
TABLE 179 ELEKTA: TOTAL REVENUE, BY GEOGRAPHY, 2008 - 2010 ($MILLION)
TABLE 180 FISHER & PAYKEL HEALTHCARE: TOTAL OPERATING REVENUE AND R&D EXPENSES, 2009 - 2011($MILLION)
TABLE 181 FISHER & PAYKEL HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 182 FISHER & PAYKEL HEALTHCARE: TOTAL REVENUE, BY SEGMENTS,
2009 - 2011 ($MILLION)
TABLE 183 FUKUDA DENSHI COMPANY LTD.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 184 FUKUDA DENSHI COMPANY LTD.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 185 GE HEALTHCARE: TOTAL REVENUE AND R&D EXPENSES,
2009 - 2011($BILLION)
TABLE 186 GE HEALTHCARE: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($BILLION)
TABLE 187 GE HEALTHCARE: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 188 HONEYWELL INTERNATIONAL INC.: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 189 HONEYWELL INTERNATIONAL INC.: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 190 HONEYWELL INTERNATIONAL INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 191 JOHNSON & JOHNSON INC.: TOTAL SALES AND R&D EXPENSES,
2009 - 2011 ($BILLION)
TABLE 192 JOHNSON & JOHNSON INC.: R&D EXPENDITURE, BY SEGMENTS,
2009 - 2011 ($BILLION)
TABLE 193 JOHNSON & JOHNSON INC.: TOTAL SALES, BY SEGMENTS, 2009 - 2011 ($BILLION)
TABLE 194 JOHNSON & JOHNSON INC.: TOTAL SALES, BY GEOGRAPHY,
2009 - 2011 ($BILLION)
TABLE 195 LARSEN & TOUBRO LTD.: TOTAL REVENUE AND R&D EXPENSES,
2009 - 2010 ($MILLION)
TABLE 196 LARSEN & TOUBRO LTD.: TOTAL REVENUE,BY SEGMENTS ($MILLION)
TABLE 197 LARSEN & TOUBRO LTD.: TOTAL REVENUE, BY GEOGRAPHY,
2009 - 2011 ($MILLION)
TABLE 198 LIFEWATCH AG: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($MILLION)
TABLE 199 LIFEWATCH AG: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 200 LIFEWATCH AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 201 MASIMO: TOTAL REVENUE AND R&D EXPENSES, 2009 - 2011 ($THOUSAND)
TABLE 202 MINDRAY: TOTAL R
To order this report:Medical Equipment and Supply Industry: Patient Monitoring Systems Market (2011 - 2016) - Global Trends, End-user & Value-Volume AnalysisMore
Market Research ReportCheck our
Industry Analysis and InsightsCONTACT
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article